Balance between consumer and healthcare providers expected to shift as home medical testing expands

Experts Examine Impact of Move from Physician-Directed Clinical Testing to Consumer Over-the-Counter (OTC) Home Diagnostics.

The shift in the relationship between patients and medical providers will continue to change the healthcare landscape as the ease of use and reliability of consumer self-diagnostic products advance, according to a group of industry, research and academic leaders that convened at a recent day-long diagnostics workshop hosted by Cambridge Consultants (www.cambridgeconsultants.com).  Yet, as the expansion of consumer diagnostics and monitoring products ery: mpower consumers to actively manage their own healthcare, new challenges and responsibilities for both consumers and the diagnostics technology industry are emerging. 

 

Read Complete story: http://www.cambridgeconsultants.com/news_pr197.shtml

 

 

Seeking a More Accurate Lab Diagnosis for Non-Alcoholic Fatty Liver Disease

A recent article about non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) caught my attention (see: Geisinger And Celera To Collaborate On Liver Disease Test) for several reasons. Here's an excerpt from it with boldface emphasis mine:

 

Read complete story: http://labsoftnews.typepad.com/lab_soft_news/2008/02/seeking-a-genet.html

Micro and nanotechnologies are revolutionising medicine

Continuous Glucose Monitoring

Wireless Glucose monitoring

India’s Dr Diagnostics

I found this situation unique. And also challenging. I spotted an opportunity here and wanted to make use of it. It was a challenging task for me as it was a politically sensitive issue too. With the support and encouragement from the experts and academicians I over came all the hurdles to develop an indigenous product to detect the HIV virus accurately," said Dr BV Ravi Kumar, chairman and managing director, XCyton Diagnostics Ltd, Bangalore

 

Read complete story: http://biospectrumindia.ciol.com/content/features/agri/10305191.asp

 

 

India's health biotech sector at a crossroads

Indian biotech is at a crossroads. It must not only address the significant health needs of its domestic population, but also position itself to take advantage of the often more profitable global marketplace. The country's health biotech companies operate in close proximity to the shocking disparities in health that plague our globe today. Although these firms are uniquely suited to address these needs, they require financial and political support before they will commit to doing so.

 

Read complete story: http://www.nature.com/nbt/journal/v25/n4/full/nbt0407-403.html;jsessionid=ECBBCF5E581327D85203FC88132936D9

 

 

Quest to set up diagnostic labs in India

Quest Diagnostics, one of the leading providers of diagnostic testing, information and services in the United States, is looking to set its footprint in India.

"We are looking to expand in India and are on the verge of opening diagnostic laboratories in the country," Dr Harvey W Kaufman, medical director international, said on Thursday while addressing a luncheon meeting on 'Business Opportunities for Healthcare and medical Tourism in India' at the Indian Consulate in New York.

 

 

Read complete story: http://www.rediff.com/money/2007/feb/23quest.htm

Quality control norms a must for all diagnostic laboratories in India

Bio-Rad Laboratories in association with Quality Council of India (QCI), Government of India, today organized a seminar on quality control (QC) in diagnostic laboratories. The seminar focussed on the need for upgrading and enforcing QC practices in laboratories all over the country.

 

Read complete story: http://www.indiaprwire.com/pressrelease/biotechnology/200709134504.htm

 

 

Path lab chains forecast consolidation in the Indian diagnostics market

With the advent of large pathology laboratories chain, the Indian diagnostics landscape has undergone some major changes in the last four to five years. One of the significant impacts has been the rising competition among the large players, which may not have cut down the prices to the consumers, but has surely raised the entry barriers for small path labs, which mushroomed in the nineties to uncontrollable proportions. Now, large path labs say that consolidation is imminent and they quote the US example which evolved in a similar way, but is today dominated by only four major chains of path labs.

 

Read complete story: http://www.expresshealthcaremgmt.com/labwatch/lab1.shtml

INDIA RIDES A WAVE OF TECHNOLOGY

India has the second largest population and ranks first among the countries worldwide with the highest number of tuberculosis cases.

According to the World Health Organization's Global Tuberculosis Control: WHO Report 2004, more than onefifth of all TB cases worldwide were in India. TB remains the leading infectious cause of death in India, killing close to 500,000 people each year. TB mainly
affects Indians of lower economic classes, who are unable to afford treatment or susceptibility testing.

 

Read complete story:

 

http://www.trekds.com/casestudies/cs_India.asp

Sneha Diagnostics will open it's two new world class diagnostics centers during February 2008

Sneha Diagnostics is a world class medical diagnsotics company providing Radiology and clinical referral lab services and health checkups at resonable prices in AP,India.

 

During a recent press conference, Mr. Venkat Mandapati (Director -operations) of Sneha Diagnostics said the work at their two new modern diagnostics centers (one at Chirala and one at Kavali,Nellore dist) is progressing well as per the schedule and will likely open during Feb 2008

 

He also informed about their plans of opening 4 modern diagnostics centers at 4 major metropolitan centers during 2008. With the exceptional quality services that they're able to provie at reasonable prices he said he's very confident that Sneha Diagnostics will be in the league of major players by year the year 2009 and expressed confidence in dominating Indian market by the year 2010.

Contact us: 5-28 Kurnool Road Ongole,AP 523002 Tel # 08592-224567/226789 www.snehadiagnostics.com

 

GE Healthcare Pursues Early Health Model in Developing Countries

I have posted a number of previous notes about GE Medical's interest in, and publicity about, the early health model (EHM). I have speculated in these notes about the significance of this new approach to healthcare delivery and its tight links to molecular medicine.

 

Read complete story: http://labsoftnews.typepad.com/lab_soft_news/2008/02/ge-healthcare-d.html

 

 

Lab at your doorstep

TAPPING an interesting business opportunity, a city-based diagnostic services firm has launched `Diagnostics @ur Doorsteps' which seeks to offer some key diagnostic services to the old, paralytic, pregnant women and patients who are immobile.

 

Read complete story: http://www.thehindubusinessline.com/2003/11/29/stories/2003112902051700.htm

High Performance HPLC

High Performance Liquid Chromatography (HPLC) is a diagnostic technique used for identifying and purifying proteins and many other molecules in the blood. It is employed for diagnosing various haemoglobin disorders in the blood like thalassemia major or minor or estimation of HbA1c for diabetes. Of the three main types of chromatography—gas (GC), liquid (LC) and supercritical fluid (SFC), HPLC falls in the SFC section.

 

Read complete story:       http://www.expresspharmaonline.com/20070228/healthcare09.shtml

Dr Lal PathLabs launches clinical research services

Dr Lal PathLabs has launched its clinical research services by opening a dedicated state-of-the-art clinical trial laboratory (central lab) at Gurgaon.

 

 

Read complete story: http://biospectrumindia.ciol.com/content/news/20705071.asp

The diagnostics industry's top league has regrouped from six players to four

The outsourcing opportunity in front of India's low-cost medical diagnostics industry has for long been touted as a low-hanging fruit.

 

Read the complete story : http://www.businessworldindia.com/SEP2605/indepth06.asp

The opportunity in the pathology labs business

The Rs 2,000-crore industry in India is going through major change. When Businessworld looked at the pathology industry a year back ('Still In The Lab', 12 July 2004 edition), there were six clear leaders.

 

Read complete story : http://www.ventureintelligence.in/blog/2005/10/opportunity-in-pathology-labs-business.html

Pathology labs flourishing in absence of Government regulation

NEW DELHI: Never shy away from bargaining when approaching any pathology laboratory for routine medical tests. With practically no price or quality yardstick regulations by the Government on various tests offered by the path labs and most of them indulging in giving commissions to doctors and medical establishments for referring patients to their centres, a patients may be paying as much as 25-50 per cent extra of the actual cost for any test

 

Read full story: http://www.hindu.com/2006/07/05/stories/2006070515060400.htm